Former Union minister Sharad Pawar on Wednesday heaped praises on Dr Cyrus Poonawalla, founder of Serum Institute of India (SII), for his work in the field of..

Natasha Poonawalla, who is enthusiastic about fashion and design. She is currently serving as the executive director of the Serum Institute of India (SII), one..

He played a crucial role as the leader of the Serum Institute of India in the large-scale production of the Covishield vaccine amid the Covid-19 pandemic.

For those not aware of the name, Adar Poonawala is the CEO of Serum Institute of India, a company that achieved great success in vaccine making and distribution..

The Bombay High Court dismissed a petition filed by Serum Institute of India Pvt Ltd challenging a 2016 amendment to the Income Tax Act, 2015. The amendment..

Yohan Poonawalla is son of Zavaray Poonawalla who co-founded biopharmaceuticals firm Serum Institute of India along with his brother Cyrus Poonawalla in 1966...

Yohan Poonawalla is the Chairman of Poonawalla Engineering Group and El-O- Matic India Pvt Ltd and he is also a shareholder in Serum Institute of India Pvt Ltd..

Cyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.

"Some people are saying that people who are senior now should give us their blessings (and retire). Why should they stop working? Ratan Tata who heads India's..

Adar Poonawalla's Serum Institute of India (SII), which became a household name for developing Covid-19 vaccines, is ranked as India's most valuable unlisted..

The Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII)..

The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII)..

The SII filed a defamation suit in December 2022 seeking damages to the tune of Rs 100 crore from the two individuals and their organisations for allegedly..

Serum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four..

The R21 vaccine, created at Oxford University and approved by the Ghanaian Food and Drugs Authority, is now available to the age group most at risk of..

Serum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to..

Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of..

Covid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for..

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a..

The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken..

Serum Institute CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed..

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days,..

Amid an alarming surge of Covid-19 cases in China, the CEO and founder of Serum Institute of India Adar Ponawalla in a tweet has urged the people not to panic...

We must continue to trust and follow the guidelines set by the Government of India, Serum Institute of India (SII) CEO Adar Poonawalla said as he expressed..

Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose..

One of the directors of the SII received WhatsApp messages from a person who posed as Adar Poonawalla. The sender asked him to transfer money to certain bank..

Fraudsters allegedly attempted to con one of SII's directors by sending him a WhatsApp message asking him to wire money to numerous other accounts.

Fraudsters duped vaccine-maker Serum Institute of India (SII) of more than Rs 1 crore by sending messages in the name of its Chief Executive Officer Adar..

Cervavac, India's first indigenously developed vaccine for preventing cervical cancer caused by Human Papilloma Virus (HPV), is likely to be priced between Rs..

India is all set to launch on Thursday its first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for prevention of cervical cancer. It..

MHRA authorised the vaccine in the UK for adult booster doses "after it met safety, quality, and efficacy requirements," the agency stated.

Serum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women..

The government has allowed Serum Institute of India (SII) to supply 32.4 lakh doses of its Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which..

 "The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the..

An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to..

Asked about concerns over the rise of monkeypox cases, Serum Institute of India Chief Executive Adar Poonawalla said he believed the "disease was not so..

Asked about concerns over the rise of monkeypox cases, Serum Institute of India Chief Executive Adar Poonawalla said he believed the "disease was not so..

Serum Institute of India (SII) CEO Adar Poonawalla on Sunday wooed Elon Musk to invest in India to manufacture Tesla electric cars, saying it will be the best..

Adar Poonawalla, CEO of Serum Institute of India, has invited Elon Musk to invest in India; this invitation comes amidst reports of Tesla CEO putting brakes on..

"A lot of you have asked if Covovax is available for adults. The answer is yes, it is available for everyone above the age of 12," Poonawalla tweeted.

Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the Covid-19 vaccine Covovax is now available in India for children. He also hailed PM..

As majority of youngsters has already taken the first dose of Covid vaccine, the government is unlikely to procure Serum Institute of India’s Covovax for use..

Serum Institute of India (SII) Director for Government and Regulatory Affairs Prakash Kumar Singh had written to the Union Health Ministry recently, r

 The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group,..

Serum Institute of India Ltd., the world’s largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped making..

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus..

Comparing the situations and availabilities of medicines and technologies in year 2020 to 2022, Serum Institute of India CEO Adar Poonawalla talked about how..

Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to six months from nine months..

Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of the precaution dose of their respective..

Serum Institute of India has reduced the price of its Covishield vaccine from Rs 600 to Rs 225 per dose for private hospitals, the vaccine maker announced on..

SII CEO Adar Poonawalla also welcomed the government's move to allow precautionary doses of the vaccine to all aged above 18 years.

Vaccine maker Serum Institute of India (SII) on Friday said the precaution dose of its Covishield vaccine against Covid-19 will be priced at Rs 600 per shot for..

Government have decided to allow Coronavirus booster shots to all adults from Sunday at private vaccination centres. The move was welcomed by Serum Institute of..

Speaking to reporters on the sidelines of the ‘Alternate Fuel Conclave’, the SII CEO said the reason behind the low number of Covid-19 cases at the moment is..

The Covid-19 working group under the government’s vaccine advisory body has recommended use of the Serum Institute of India’s Covovax in the national..

According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of..

Novavax Inc on Tuesday said that the Drugs Controller General of India (DCGI) has granted emergency use authorisation for its Covid-19 vaccine for adolescents..

In a move that will further expand the basket of Covid vaccines approved for adolescents, the drug regulator has given emergency approval to Serum Institute of..

"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and..

India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group..

Prakash Kumar Singh, director-government and regulatory affairs at Serum Institute of India (SII), had submitted an application to the DCGI on February 21,..

India has approved nine COVID-19 vaccines up until now, of which three - Serum Institute of India's Covishield, Bharat Biotech's Covaxin and Russian vaccine..

A group of 230 children aged two to six have become the youngest in the country to get a Covid vaccine after they were given at least one dose during trials of..